§ 27-55-1. Definitions. For the purpose of this chapter, the following words and terms have the following meanings: (1) “Drug” or “drugs” means any substance prescribed by a licensed healthcare provider acting within the scope of the provider’s license and that is intended for use in the diagnosis, mitigation, treatment or prevention of disease that […]
§ 27-55-2. Prescription drug coverage. (a) No health insurer issuing a policy which provides coverage for prescription drugs shall exclude coverage of any drug used for the treatment of cancer or disabling or life-threatening chronic disease on the grounds that the drug has not been approved by the FDA for that indication; provided that the […]
§ 27-55-3. Advisory panel on off-label uses of prescription drugs. The director of the department of health shall appoint an advisory panel of seven (7) medical experts. The purpose of the advisory panel is to make recommendations to the director regarding whether a particular off-label use is medically appropriate, whenever a particular dispute about payment […]
